128 related articles for article (PubMed ID: 8971536)
1. Treatment of men with flat (FC) or acuminata (CA) condylomata with interferon alpha-2a.
Relakis K; Cardamakis E; Korantzis A; Metalinos K; Mantouvalos H; Papathanasiou Z; Michopoulos J; Stathopoulos E; Kotoulas IG; Tzingounis V
Eur J Gynaecol Oncol; 1996; 17(6):529-33. PubMed ID: 8971536
[TBL] [Abstract][Full Text] [Related]
2. Treatment of penile intraepithelial neoplasia (PIN) with interferon alpha-2a, CO2 laser (vaporization) and 5-fluorouracil 5% (5-FU).
Cardamakis E; Relakis K; Ginopoulos P; Korantzis A; Metalinos K; Stathopoulos E; Papathanasiou Z; Michopoulos J; Mantouvalos H; Kotoulas IG; Tzingounis V
Eur J Gynaecol Oncol; 1997; 18(5):410-3. PubMed ID: 9378164
[TBL] [Abstract][Full Text] [Related]
3. Treatment of urethral condylomata acuminata or flat condylomata with interferon-alpha 2a.
Cardamakis E; Kotoulas IG; Metalinos K; Mantouvalos H; Relakis K; Scarpari M; Korantzis A; Papathanasiou Z
J Urol; 1994 Dec; 152(6 Pt 1):2011-3. PubMed ID: 7966664
[TBL] [Abstract][Full Text] [Related]
4. 5-FU for genital warts in non-immunocompromised individuals.
Batista CS; Atallah AN; Saconato H; da Silva EM
Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD006562. PubMed ID: 20393949
[TBL] [Abstract][Full Text] [Related]
5. Interferon alpha-2b injections used as an adjuvant therapy to carbon dioxide laser vaporization of recalcitrant ano-genital condylomata acuminata.
Vance JC; Davis D
J Invest Dermatol; 1990 Dec; 95(6 Suppl):146S-148S. PubMed ID: 2124244
[TBL] [Abstract][Full Text] [Related]
6. Treatment of flat or accuminata condylomata of the female genital tract with interferon alpha-2 alpha.
Relakis K; Cardamakis E; Korantzis A; Kotoulas I; Stathopoulos E; Metalinos K; Papathanasiou Z; Mantouvalos H; Tzingounis V; Koumantakis E
Oncol Rep; 1996 Sep; 3(5):951-5. PubMed ID: 21594489
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study.
Szeimies RM; Schleyer V; Moll I; Stocker M; Landthaler M; Karrer S
Dermatol Surg; 2009 May; 35(5):757-64. PubMed ID: 19389107
[TBL] [Abstract][Full Text] [Related]
8. Treatment of genital HPV infection with carbon dioxide laser and systemic interferon alpha-2b.
Nieminen P; Aho M; Lehtinen M; Vesterinen E; Vaheri A; Paavonen J
Sex Transm Dis; 1994; 21(2):65-9. PubMed ID: 9071414
[TBL] [Abstract][Full Text] [Related]
9. Treatment of cervical intraepithelial neoplasia (CIN) with interferon alpha-2a, CO2 laser (vaporization, cone) and 5-fluorouracil.
Cardamakis E; Koumantakis E; Relakis C; Kotoulas I; Korantzis A; Mantouvalos H; Metalinos C; Stathopoulos E; Tzingounis V
Oncol Rep; 1996 May; 3(3):531-4. PubMed ID: 21594406
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil versus 5-fluorouracil plus alpha-interferon as treatment of metastatic colorectal carcinoma. A randomized study.
Dufour P; Husseini F; Dreyfus B; Cure H; Martin C; Prevost G; Olivier JP; Dumas F; Duclos B; Olivares R; Leszler A; Bergerat JP; Audhuy B; Thill L; Oberling F
Ann Oncol; 1996 Aug; 7(6):575-9. PubMed ID: 8879370
[TBL] [Abstract][Full Text] [Related]
11. Combination of laser plus 5-fluorouracil for the treatment of extensive genital condylomata acuminata.
Krebs HB
Lasers Surg Med; 1988; 8(2):135-8. PubMed ID: 3367679
[TBL] [Abstract][Full Text] [Related]
12. Initial experience with combined interferon-alpha 2B and carbon dioxide laser for the treatment of condylomata acuminata.
Davis BE; Noble MJ
J Urol; 1992 Mar; 147(3):627-9. PubMed ID: 1538444
[TBL] [Abstract][Full Text] [Related]
13. Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.
Gross G; Roussaki A; Baur S; Wiegand M; Mescheder A
Genitourin Med; 1996 Feb; 72(1):71. PubMed ID: 8655177
[No Abstract] [Full Text] [Related]
14. Phase I and II trials of subcutaneously administered rIL-2, interferon alfa-2a, and fluorouracil in patients with metastatic renal carcinoma.
Olencki T; Peereboom D; Wood L; Budd GT; Novick A; Finke J; McLain D; Elson P; Bukowski RM
J Cancer Res Clin Oncol; 2001 May; 127(5):319-24. PubMed ID: 11355147
[TBL] [Abstract][Full Text] [Related]
15. A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata.
Armstrong DK; Maw RD; Dinsmore WW; Morrison GD; Pattman RS; Watson PG; Nathan PM; Moss T; Nayagam A; Wade A
Genitourin Med; 1994 Dec; 70(6):389-93. PubMed ID: 7705855
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 5-fluorouracil and CO2 laser for treatment of vaginal condylomata.
Ferenczy A
Obstet Gynecol; 1984 Dec; 64(6):773-8. PubMed ID: 6504421
[TBL] [Abstract][Full Text] [Related]
17. Recurrent condylomata acuminata treated with recombinant interferon alpha-2a. A multicenter double-blind placebo-controlled clinical trial. Condylomata International Collaborative Study Group.
Acta Derm Venereol; 1993 Jun; 73(3):223-6. PubMed ID: 8105627
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and effects of adjuvant therapy in colon cancer: results of the German prospective, controlled randomized multicenter trial FOGT-1.
Staib L; Link KH; Beger HG;
J Gastrointest Surg; 2001; 5(3):275-81. PubMed ID: 11419451
[TBL] [Abstract][Full Text] [Related]
19. Randomized placebo-controlled double-blind combined therapy with laser surgery and systemic interferon-alpha 2a in the treatment of anogenital condylomata acuminatum. The Condylomata International Collaborative Study Group.
J Infect Dis; 1993 Apr; 167(4):824-9. PubMed ID: 8450247
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of recombinant human interferon-alpha 2a combined with 5-fluorouracil in patients with advanced colorectal carcinoma.
Kim J; Zhi J; Satoh H; Koss-Twardy SG; Passe SM; Patel IH; Pazdur R
Anticancer Drugs; 1998 Sep; 9(8):689-96. PubMed ID: 9823427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
